News Overview

Johnson & Johnson opens Innovation Hub at the Main Campus

Arianna Ramirez

Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area – Main Campus. This represents an extension of J&J Innovation in London and is intended to serve as a bridge to external innovations.

Sarah Mueller, Nerida Scott, Michael R Huebner 
and Emmanuelle Quiles (from left to right) at 
the opening event in Allschwil (image: Johnson & Johnson)

Johnson & Johnson has opened its first multi-purpose meeting room in its J&J office space on the Main Campus of the Switzerland Innovation Park Basel Area in Allschwil in the canton of Basel-Landschaft. Known as the Swiss Innovation Hub, this is the North American pharma group’s first such facility located on the European mainland.

The hub, which is managed by Michael R. Hübner, Early Innovation Partner for J&J Innovation, serves as a key extension of J&J Innovation based at the London Innovation Center. “We know true innovation takes a village and so we’re continually seeking the most promising early innovations around the world that could benefit from our insight and collaboration”, Hübner says.


Basel Area as a “top region for scientific innovation”


In this sense, the Innovation Hub is designed to promote contacts with external collaborators from “the abundant innovation ecosystem in Switzerland and neighboring countries”, as Nerida Scott, Head of J&J Innovation EMEA, writes in a LinkedIn post. During the event to mark the opening of the hub, those in attendance learned from both her and the Swiss leadership team all about “the vital role played by Basel, and Switzerland as a whole, in both biotech and medtech innovation, and Johnson & Johnson’s continued commitment to the region”. In Switzerland, Johnson & Johnson employs more than 5,700 staff across both areas. Emmanuelle Quiles, Worldwide Vice President Cardiovascular, Metabolism and Pulmonary Hypertension at Johnson & Johnson, also underlines the importance of the Basel Area. She described it as one of the “top regions for scientific innovation in the world”.

Christof Klöpper, CEO of the investment and innovation promotion agency Basel Area Business & Innovation, also discussed the opening of the Innovation Hub. He highlighted the fact that Switzerland is a globally leading region in terms of innovation in the fields of medical devices and new medicines, in addition to boasting a rich talent pool.

J&J moved to this site just five months ago, joining other pharma and mature biotech companies, as well as startups and incubators, in one of the top regions for scientific innovation in the world. Today, Switzerland houses over 5,700 employees across our Johnson & Johnson Innovative Medicine and Johnson & Johnson MedTech sectors. The Hub will be an important addition to J&J Innovation, based at the London Innovation Center.”

Emmanuelle Quiles
Worldwide Vice-President Cardiovascular, Metabolism & Pulmonary at Johnson & Johnson

Learn more about the Main Campus

You may also like

Switzerland’s densest innovation ecosystem

Located in the heart of Europe, our vibrant ecosystem provides an ideal breeding ground for cutting-edge…> Read more

Engimmune and CSEM’s proximity accelerates their collaboration to revolutionize cancer treatment

The collaboration between Engimmune Therapeutics and the Swiss Technology Innovation Center CSEM accelerates cancer screening. Their shared success…> Read more
The best coworking spaces in Basel - Header

The 14 best coworking spaces in the Basel Area [with prices].

The Basel Area is the ideal ecosystem for startups and established companies. We made this list…> Read more

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.